MacroGenics Inc Stock Plunges Over 50% After Trial Results Reveal High Adverse Events Rate

On May 10, 2024, in an alarming development, MacroGenics Inc, based in Rockville, Maryland, revealed concerning interim data from the TAMARACK Phase 2 study. The study focused on vobramitamab duocarmazine (vobra duo), a treatment targeting B7-H3, which is found in various solid tumors. Specifically, the study targeted previously treated patients with metastatic castration-resistant prostate cancer (mCRPC). Following the release of the data, MacroGenics shares plummeted by over 50% as the company disclosed five deaths during …

Read more

Side Effects Spike: Regeneron’s ‘Best-in-Class’ Myeloma Drug Causes 100% Adverse Reactions

Houston, TX – A new study on Regeneron’s myeloma drug has revealed significant side effects, with 100% of participants experiencing adverse reactions. The drug, described as ‘best-in-class’ by researchers, is drawing attention for its powerful impact on multiple myeloma patients. The clinical trial, conducted in Houston, TX, involved a diverse group of patients with varying degrees of the disease. Despite the promising results in terms of efficacy, the high incidence of side effects raises concerns …

Read more

“Tragic Plane Crash Claims Lives of Former Afghan Air Force Members in Oregon” – Complacency in Adverse Weather Led to Fatal Incident

INDEPENDENCE, Oregon – A tragic plane crash claimed the lives of three former Afghan Air Force members who were in Oregon training for a commercial license. The incident, which occurred two weeks ago, highlighted the risks faced by former Afghan forces training in the U.S. and the importance of strict compliance with safety protocols in aviation. The ill-fated crash happened when the pilot, against the advice of his flight instructor, decided to return to a …

Read more